SonoScape Medical Corp (300633) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SonoScape Medical Corp (300633) has a cash flow conversion efficiency ratio of -0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-130.62 Million ≈ $-19.11 Million USD) by net assets (CN¥3.12 Billion ≈ $456.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SonoScape Medical Corp (300633) market capitalisation for the company's overall valuation and market capitalisation.
SonoScape Medical Corp - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how SonoScape Medical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
SonoScape Medical Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SonoScape Medical Corp ranked by their cash flow conversion efficiency. Explore SonoScape Medical Corp cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chemtrade Logistics Income Fund
TO:CHE-UN
|
0.206x |
|
United Corporations Limited
TO:UNC
|
0.004x |
|
Collective Mining Ltd
TO:CNL
|
-0.091x |
|
Vossloh AG
F:VOS
|
-0.046x |
|
Jiangsu Favored Nanotechnology Co. Ltd. A
SHG:688371
|
N/A |
|
Temple Bar Investment Trust
LSE:TMPL
|
0.014x |
|
Ingles Markets Incorporated
NASDAQ:IMKTA
|
0.040x |
|
Suzhou Kingswood Printing Ink Co Ltd
SHE:300192
|
0.010x |
Annual Cash Flow Conversion Efficiency for SonoScape Medical Corp (2012–2025)
The table below shows the annual cash flow conversion efficiency of SonoScape Medical Corp from 2012 to 2025. View SonoScape Medical Corp stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.26 Billion ≈ $477.40 Million |
CN¥-48.16 Million ≈ $-7.05 Million |
-0.015x | -114.96% |
| 2024-12-31 | CN¥3.11 Billion ≈ $454.83 Million |
CN¥306.66 Million ≈ $44.87 Million |
0.099x | -37.15% |
| 2023-12-31 | CN¥3.15 Billion ≈ $460.35 Million |
CN¥493.88 Million ≈ $72.27 Million |
0.157x | -9.12% |
| 2022-12-31 | CN¥2.74 Billion ≈ $400.92 Million |
CN¥473.26 Million ≈ $69.25 Million |
0.173x | +34.27% |
| 2021-12-31 | CN¥2.36 Billion ≈ $344.64 Million |
CN¥302.99 Million ≈ $44.34 Million |
0.129x | -36.18% |
| 2020-12-31 | CN¥1.34 Billion ≈ $196.81 Million |
CN¥271.13 Million ≈ $39.68 Million |
0.202x | +48.68% |
| 2019-12-31 | CN¥1.40 Billion ≈ $205.49 Million |
CN¥190.39 Million ≈ $27.86 Million |
0.136x | -23.93% |
| 2018-12-31 | CN¥1.31 Billion ≈ $191.84 Million |
CN¥233.65 Million ≈ $34.19 Million |
0.178x | +38.62% |
| 2017-12-31 | CN¥1.06 Billion ≈ $155.02 Million |
CN¥136.21 Million ≈ $19.93 Million |
0.129x | -32.61% |
| 2016-12-31 | CN¥720.11 Million ≈ $105.38 Million |
CN¥137.38 Million ≈ $20.10 Million |
0.191x | +91.91% |
| 2015-12-31 | CN¥566.21 Million ≈ $82.85 Million |
CN¥56.29 Million ≈ $8.24 Million |
0.099x | -61.06% |
| 2014-12-31 | CN¥444.81 Million ≈ $65.09 Million |
CN¥113.55 Million ≈ $16.62 Million |
0.255x | +3.61% |
| 2013-12-31 | CN¥365.08 Million ≈ $53.42 Million |
CN¥89.94 Million ≈ $13.16 Million |
0.246x | +459.62% |
| 2012-12-31 | CN¥351.82 Million ≈ $51.48 Million |
CN¥15.49 Million ≈ $2.27 Million |
0.044x | -- |
About SonoScape Medical Corp
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, ligh… Read more